Health Boards
Sat-13-08-2022, 10:33 AM
Update: The U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis.
|
Tremfya going after psoriatic arthritis
|
Sun-14-08-2022, 18:18 PM
To be honest, non of the IL23s seem to work for the back, at least not for me.
 (Sun-14-08-2022, 18:18 PM)mataribot Wrote: To be honest, non of the IL23s seem to work for the back, at least not for me. I can imagine that. Personally I have the idea that the IL23’s are more related to psoriasis and that the IL17’s and IL17A’s are more related to Psoriatic Arthritis. Considering all the examples over here on psoriasisclub. |
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Psoriasis to psoriatic arthritis characterised by alterations in T cells | Fred | 1 | 267 |
Wed-17-09-2025, 20:43 PM Last Post: Caroline |
|
|
Tremfya goes for psoriatic arthritis | Fred | 2 | 729 |
Thu-21-08-2025, 16:19 PM Last Post: Fred |
|
|
Sotyktu accepted for review in psoriatic arthritis | Fred | 0 | 799 |
Tue-22-07-2025, 11:41 AM Last Post: Fred |
|
|
Ilumya / Ilumetri phase 3 for psoriatic arthritis | Fred | 0 | 700 |
Tue-22-07-2025, 11:24 AM Last Post: Fred |
|
|
Spyre SPY072 for psoriatic arthritis phase 1 | Fred | 1 | 1,072 |
Thu-17-07-2025, 20:15 PM Last Post: Caroline |
Users browsing this thread: 2 Guest(s)